Neurocrine Biosciences | NBIX - Eps Ganancias Por Acción


Fiscal Calendario Real Consenso Anterior Fecha
FY2026Q3 Sep/2025 2.05 2.17 Nov/03
FY2026Q2 Jun/2026 2.85 1.58 1.65 Jul/30
FY2026Q1 Mar/2026 1.94 1.15 0.70 May/05
FY2025Q4 Dec/2025 1.88 1.86 1.69 Feb/11
FY2025Q3 Sep/2025 2.17 1.56 1.81 Oct/28




Eps Cambio Fecha
AbbVie USD 3.65 1 2026-06
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
ALKERMES USD 0 0.4 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amgen USD 6.29 1.14 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Cytokinetics USD -1.5 0.17 2026-06
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Exelixis USD 0.91 0.04 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
Halozyme Therapeutics USD 2.28 0.68 2026-06
Incyte USD 3.09 1.28 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Nektar Therapeutics USD -1.78 0.43 2026-03
Neurocrine Biosciences USD 2.85 0.91 2026-06
Pfizer USD 0.77 0.02 2026-06
Prothena USD 0.6 1.06 2026-03
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Repligen USD 0.54 0.06 2026-06
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sarepta Therapeutics USD 0.64 2.52 2026-06
Teva Pharmaceutical Industries USD 0.06 1.51 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06